GlassScriptPhysician profile
Parham Eshtehardi
NPI 1821359019
$3,624.89
in general payments reported to CMS, 2019-2025
23 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $179 · 2021: $242 · 2022: $455 · 2023: $1,138 · 2024: $967 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $845.35 | 2020-2025 | Lifevest |
| Pfizer INC. | $495.17 | 2022-2025 | |
| Boston Scientific Corporation | $326.86 | 2021-2024 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $271.20 | 2023-2025 | |
| Amgen INC. | $234.75 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $188.54 | 2022-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $168.75 | 2022-2024 | Xarelto |
| Esperion Therapeutics, INC. | $159.33 | 2020-2024 | Nexletol |
| Atricure, INC. | $142.33 | 2025 | Synergy Ablation System |
| Janssen Scientific Affairs, LLC | $132.80 | 2024 | Xarelto |
| Shockwave Medical, INC | $128.60 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $96.46 | 2020-2025 | Wainua |
| Alnylam Pharmaceuticals INC. | $63.93 | 2024-2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $59.15 | 2023-2025 | Mitraclip, Jot Dx |
| Kiniksa Pharmaceuticals International, Plc | $58.63 | 2024 | Arcalyst |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $44.89 | 2023-2025 | Definity |
| Heartflow, INC. | $44.64 | 2023-2025 | Ffrct |
| Kestra Medical Technology Services, INC. | $39.31 | 2023-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $37.62 | 2021-2022 | |
| Cvrx, INC. | $29.84 | 2023-2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $26.52 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $15.95 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.27 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parham Eshtehardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.